BRAF and cutaneous melanoma: BRAF is a proto-oncogene belonging to the RAF family of serine-threonine protein kinases; 50% of patients with cutaneous melanoma have BRAF mutations, with the glutamic acid for valine substitution at position 600 (V600E) representing about 90% of all BRAF mutations.